Outpatient phototherapy for psoriasis.

Outpatient phototherapy for psoriasis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Outpatient phototherapy for psoriasis. Abstract Text:

Using a new protocol with varied exposure increments, we found that, in 18 of 20 patients with psoriasis vulgaris who were given ultraviolet (UV)-B phototherapy three times a week, the disease completely cleared. One patient's condition substantially improved, and one patient's condition failed to respond. Ten to 38 treatments were required during a three- to 13-week period. The only topical treatment agent used was white petrolatum. The results are compared with a schedule using five treatments a week and fixed UV-B--exposure increments. Infrequent (three times weekly) treatments, avoidance of hospitalization and crude coal tar treatment, and fewer episodes of UV-radiation burn may offer advantages for selected patients. Long-term effects and maintenance requirements for this treatment regimen are not known.

Outpatient phototherapy for psoriasis. Publishing Authors By Initials

For similar therapeutics: phototherapy: ultraviolet therapy research abstracts see: therapeutics: phototherapy: ultraviolet therapy research

PUBMED ID PMID:

MEDLINE DATE:

Outpatient phototherapy for psoriasis. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Archives of dermatology

VOLUME: 117

Page Numbers: 623-6

Journal Abbreviation: Arch Dermatol

ISSN: 0003-987X

DAY: 17

MONTH: Oct

YEAR: 1981

Outpatient phototherapy for psoriasis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372433

Outpatient phototherapy for psoriasis. Keywords Mesh Terms:

KEYWORDS: Ultraviolet Therapy

MESH TERMS: methods

Chemical & Substance for Abstract: Outpatient phototherapy for psoriasis. Information

Substance Name: Petrolatum

Registry Number: 8009-03-8

Grant and Affiliation Information for Outpatient phototherapy for psoriasis.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Outpatient phototherapy for psoriasis Related Publications

• A 1:1 copper-dioxygen adduct is an end-on bound superoxo copper(II) complex which undergoes oxygenation reactions with phenols.
• An iron-peroxo porphyrin complex: new synthesis and reactivity toward a Cu(II) complex giving a heme-peroxo-copper adduct.
• Aryl hydroxylation from a mononuclear copper-hydroperoxo species.
• Contrasting copper-dioxygen chemistry arising from alike tridentate alkyltriamine copper(I) complexes.
• Copper(I) and copper(II) complexes possessing cross-linked imidazole-phenol ligands: structures and dioxygen reactivity.
• Copper(I) complex O(2)-reactivity with a N(3)S thioether ligand: a copper-dioxygen adduct including sulfur ligation, ligand oxygenation, and comparisons with all nitrogen ligand analogues.
• Copper(I)/S(8) reversible reactions leading to an end-on bound dicopper(II) disulfide complex: nucleophilic reactivity and analogies to copper-dioxygen chemistry.
• Copper(II)-hydroperoxo complex induced oxidative N-dealkylation chemistry.
• Dioxygen reactivity of a copper(I) complex with a N3S thioether chelate; peroxo-dicopper(II) formation including sulfur-ligation.
• Distinguishing rate-limiting electron versus H-atom transfers in Cu2O2-mediated oxidative N-dealkylations: application of inter- versus intramolecular kinetic isotope effects.
• Exogenous nitrile substrate hydroxylation by a new dicopper-hydroperoxide complex.
• Further insights into the spectroscopic properties, electronic structure, and kinetics of formation of the heme-peroxo-copper complex [(F8TPP)FeIII-(O2(2-)-CuII(TMPA)]+.
• Generation and characterization of [(P)M-(X)-Co(TMPA)]n+ assemblies; P = Porphyrinate, M = FeIII and CoIII, X = O2-, OH-, O2(2-), and TMPA = tris(2-pyridylmethyl)amine.
• Heme/Cu/O2 reactivity: change in FeIII-(O2 2-)-CuII unit peroxo binding geometry effected by tridentate copper chelation.
• Kinetically reduced local Navier-Stokes equations for simulation of incompressible viscous flows.
• Outpatient phototherapy for psoriasis.
• Reaction of elemental sulfur with a copper(I) complex forming a trans-mu-1,2 end-on disulfide complex: new directions in copper-sulfur chemistry.
• Reactivity studies on Fe(III)-(O2(2-))-Cu(II) compounds: influence of the ligand architecture and copper ligand denticity.
• Synthesis and X-ray absorption spectroscopy structural studies of Cu(I) complexes of histidylhistidine peptides: the predominance of linear 2-coordinate geometry.
• Thioether sulfur oxygenation from O2 or H2O2 reactivity of copper complexes with tridentate N2Sthioether ligands.
• Thiol-copper(I) and disulfide-dicopper(I) complex O(2)-reactivity leading to sulfonate-copper(II) complex or the formation of a cross-linked thioether-phenol product with phenol addition.
• Tuning copper-dioxygen reactivity and exogenous substrate oxidations via alterations in ligand electronics.
• [Effect of partial pancreatectomy on motor function of the gastrointestinal tract.]
• [Folate content of large mixture of milks. Effect of different thermic treatments on the amount of folates, B12 and B6 of these milks]
• [Formation of the vitamin B12 content in cheeses during preparation, ripening and storage.]
• [ON THE BIOSYNTHESIS OF VITAMIN B12 AND OTHER VITAMINS OF GROUP B BY A CHROMOGENIC BACTERIUM ISOLATED FROM CHEESE.]
• [On the determination of folic acid activity of human blood in controls and in different pathological states]
• [On the enrichment of kefir with vitamin B 12 by addition of Propionibacterium shermanii. Development of levels of different vitamins during preparation and preservation]
• [Studies on variation in the content of vitamin B-6 in human and cow's milk. The effect of pyridoxine on the vitamin content of human milk.]
• [Study on the levels of folic acid in human milk and cow's milk]